Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.

Saved in:
Bibliographic Details
Title: Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
Authors: Scaricamazza, Eugenia (AUTHOR), Colonna, Isabella (AUTHOR), Sancesario, Giulia Maria (AUTHOR), Assogna, Francesca (AUTHOR), Orfei, Maria Donata (AUTHOR), Franchini, Flaminia (AUTHOR), Sancesario, Giuseppe (AUTHOR), Mercuri, Nicola Biagio (AUTHOR), Liguori, Claudio (AUTHOR)
Source: Neurological Sciences. Jul2019, Vol. 40 Issue 7, p1377-1382. 6p. 2 Charts.
Subjects: Alzheimer's patients, Mild cognitive impairment, Alzheimer's disease, Scientific observation
Abstract: Alzheimer's disease (AD) is the most common form of dementia characterized by the prevalent memory impairment. Mild cognitive impairment (MCI) may represent the early stage of AD, in particular when MCI patients show biomarkers consistent with AD pathology (MCI due to AD). Neuropsychiatric symptoms (NPS) frequently affect both MCI and AD patients. Cerebrospinal-fluid (CSF) tau and β-amyloid42 (Aβ42) levels are actually considered the most sensitive and specific biomarkers for AD neurodegeneration. In the present retrospective observational study, we evaluated CSF biomarkers and neuropsychological data (also including NPS measured by the neuropsychiatric inventory-NPI) in a population of patients affected by MCI due to AD compared with mild to moderate AD patients. We documented higher NPI scores in MCI compared with AD patients. In particular, sub-items related to sleep, appetite, irritability, depression, and anxiety were higher in MCI than AD. We also found the significant correlation between NPS and CSF AD biomarkers in the whole population of MCI and AD patients. Consistently, t-tau/Aβ42 ratio correlated with NPS in all the MCI and AD patients. These results suggest the more prevalent occurrence of NPS in MCI patients showing AD pathology and converting to dementia than AD patients. Moreover, a more significant degree of AD neurodegeneration, featured by high t-tau/Aβ42 ratio, correlated with more severe NPS, thus supposing that in MCI and AD patients a more extensive AD neurodegeneration is related to more severe behavioral disturbances. [ABSTRACT FROM AUTHOR]
Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 137026834
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Scaricamazza%2C+Eugenia%22">Scaricamazza, Eugenia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Colonna%2C+Isabella%22">Colonna, Isabella</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sancesario%2C+Giulia+Maria%22">Sancesario, Giulia Maria</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Assogna%2C+Francesca%22">Assogna, Francesca</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Orfei%2C+Maria+Donata%22">Orfei, Maria Donata</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Franchini%2C+Flaminia%22">Franchini, Flaminia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sancesario%2C+Giuseppe%22">Sancesario, Giuseppe</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mercuri%2C+Nicola+Biagio%22">Mercuri, Nicola Biagio</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liguori%2C+Claudio%22">Liguori, Claudio</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Jul2019, Vol. 40 Issue 7, p1377-1382. 6p. 2 Charts.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Alzheimer's+patients%22">Alzheimer's patients</searchLink><br /><searchLink fieldCode="DE" term="%22Mild+cognitive+impairment%22">Mild cognitive impairment</searchLink><br /><searchLink fieldCode="DE" term="%22Alzheimer's+disease%22">Alzheimer's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Scientific+observation%22">Scientific observation</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Alzheimer's disease (AD) is the most common form of dementia characterized by the prevalent memory impairment. Mild cognitive impairment (MCI) may represent the early stage of AD, in particular when MCI patients show biomarkers consistent with AD pathology (MCI due to AD). Neuropsychiatric symptoms (NPS) frequently affect both MCI and AD patients. Cerebrospinal-fluid (CSF) tau and β-amyloid42 (Aβ42) levels are actually considered the most sensitive and specific biomarkers for AD neurodegeneration. In the present retrospective observational study, we evaluated CSF biomarkers and neuropsychological data (also including NPS measured by the neuropsychiatric inventory-NPI) in a population of patients affected by MCI due to AD compared with mild to moderate AD patients. We documented higher NPI scores in MCI compared with AD patients. In particular, sub-items related to sleep, appetite, irritability, depression, and anxiety were higher in MCI than AD. We also found the significant correlation between NPS and CSF AD biomarkers in the whole population of MCI and AD patients. Consistently, t-tau/Aβ42 ratio correlated with NPS in all the MCI and AD patients. These results suggest the more prevalent occurrence of NPS in MCI patients showing AD pathology and converting to dementia than AD patients. Moreover, a more significant degree of AD neurodegeneration, featured by high t-tau/Aβ42 ratio, correlated with more severe NPS, thus supposing that in MCI and AD patients a more extensive AD neurodegeneration is related to more severe behavioral disturbances. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=137026834
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10072-019-03840-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 1377
    Subjects:
      – SubjectFull: Alzheimer's patients
        Type: general
      – SubjectFull: Mild cognitive impairment
        Type: general
      – SubjectFull: Alzheimer's disease
        Type: general
      – SubjectFull: Scientific observation
        Type: general
    Titles:
      – TitleFull: Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Scaricamazza, Eugenia
      – PersonEntity:
          Name:
            NameFull: Colonna, Isabella
      – PersonEntity:
          Name:
            NameFull: Sancesario, Giulia Maria
      – PersonEntity:
          Name:
            NameFull: Assogna, Francesca
      – PersonEntity:
          Name:
            NameFull: Orfei, Maria Donata
      – PersonEntity:
          Name:
            NameFull: Franchini, Flaminia
      – PersonEntity:
          Name:
            NameFull: Sancesario, Giuseppe
      – PersonEntity:
          Name:
            NameFull: Mercuri, Nicola Biagio
      – PersonEntity:
          Name:
            NameFull: Liguori, Claudio
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2019
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 15901874
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Neurological Sciences
              Type: main
ResultId 1